Norman Payson Sells 6,618 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
Norman Payson Sells 6,618 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
Progyny, Inc. (NASDAQ:PGNY – Get Rating) Director Norman Payson sold 6,618 shares of the firm's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $32.27, for a total value of $213,562.86. Following the transaction, the director now directly owns 411,412 shares of the company's stock, valued at approximately $13,276,265.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
纳斯达克：PGNY-GET评级)董事诺曼·佩森在8月3日周三的一笔交易中出售了6618股该公司股票。这些股票的平均价格为32.27美元，总价值为213,562.86美元。交易完成后，董事现在直接持有该公司411,412股股票，价值约13,276,265.24美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，这份文件可以在美国证券交易委员会的网站上找到。
Norman Payson also recently made the following trade(s):
诺曼·佩森最近还进行了以下交易：
- On Wednesday, July 20th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $33.40, for a total value of $221,041.20.
- On Wednesday, July 6th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $29.38, for a total value of $194,436.84.
- On Wednesday, June 22nd, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $27.35, for a total value of $181,002.30.
- On Wednesday, May 25th, Norman Payson sold 6,618 shares of Progyny stock. The shares were sold at an average price of $32.09, for a total value of $212,371.62.
- On Wednesday, May 11th, Norman Payson sold 6,618 shares of Progyny stock. The stock was sold at an average price of $33.45, for a total value of $221,372.10.
- 7月20日，星期三，诺曼·佩森出售了6,618股Progyny股票。这些股票的平均价格为33.40美元，总价值为221,041.20美元。
- 7月6日，星期三，诺曼·佩森出售了6,618股Progyny股票。这些股票的平均价格为29.38美元，总价值为194,436.84美元。
- 6月22日，星期三，诺曼·佩森出售了6,618股Progyny股票。这些股票的平均价格为27.35美元，总价值为181,002.30美元。
- 5月25日，星期三，诺曼·佩森出售了6,618股Progyny股票。这些股票的平均价格为32.09美元，总价值为212,371.62美元。
- 5月11日，星期三，诺曼·佩森出售了6,618股Progyny股票。这只股票的平均售价为33.45美元，总价值为221,372.10美元。
Progyny Price Performance
孕期性价比
PGNY opened at $41.15 on Friday. The stock has a 50-day moving average price of $30.23 and a 200-day moving average price of $37.32. The firm has a market cap of $3.78 billion, a PE ratio of 89.46, a P/E/G ratio of 15.71 and a beta of 1.85. Progyny, Inc. has a 1 year low of $25.67 and a 1 year high of $68.32.
上周五，纽约商品交易所开盘报41.15美元。该股的50日移动均线价格为30.23美元，200日移动均线价格为37.32美元。该公司市值为37.8亿美元，市盈率为89.46倍，市盈率为15.71倍，贝塔系数为1.85。Progyny，Inc.的一年低点为25.67美元，一年高位为68.32美元。
Hedge Funds Weigh In On Progyny
对冲基金对Progyny的看法
Several large investors have recently modified their holdings of PGNY. National Bank of Canada FI purchased a new position in shares of Progyny in the 2nd quarter worth about $29,000. First Horizon Advisors Inc. raised its position in Progyny by 1,469.4% in the 4th quarter. First Horizon Advisors Inc. now owns 769 shares of the company's stock worth $38,000 after buying an additional 720 shares during the last quarter. Fifth Third Bancorp raised its position in Progyny by 1,532.4% in the 4th quarter. Fifth Third Bancorp now owns 1,208 shares of the company's stock worth $61,000 after buying an additional 1,134 shares during the last quarter. Steward Partners Investment Advisory LLC raised its position in Progyny by 44.8% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,209 shares of the company's stock worth $61,000 after buying an additional 374 shares during the last quarter. Finally, Lazard Asset Management LLC purchased a new position in Progyny in the 1st quarter worth about $62,000. Hedge funds and other institutional investors own 82.51% of the company's stock.
几家大型投资者最近调整了对PGNY的持股。加拿大国民银行FI在第二季度购买了Progyny的新头寸，价值约29,000美元。First Horizon Advisors Inc.在第四季度将其在Progyny的头寸提高了1,469.4%。First Horizon Advisors Inc.现在持有该公司769股股票，价值3.8万美元，该公司在上个季度又购买了720股。Five Third Bancorp在第四季度将其在Progyny的头寸提高了1,532.4%。Five Third Bancorp现在拥有1,208股该公司股票，价值61,000美元，在上个季度又购买了1,134股。Steward Partners Investment Consulting LLC在第四季度将其在Progyny的头寸提高了44.8%。Steward Partners Investment Consulting LLC现在拥有1,209股该公司股票，价值61,000美元，上个季度又购买了374股。最后，Lazard Asset Management LLC在第一季度购买了Progyny的一个新头寸，价值约62,000美元。对冲基金和其他机构投资者持有该公司82.51%的股票。
About Progyny
关于Progyny
(Get Rating)
(获取评级)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Progyny，Inc.是一家福利管理公司，专门为美国雇主提供生育和家庭建设福利解决方案。其生育福利解决方案包括差异化福利计划设计、个性化礼宾式会员支持服务和有选择的生育专家网络。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It's Cheap
- Why Apple Could Be At All-Time Highs By Year End
- 免费获取StockNews.com关于Progyny的研究报告(PGNY)
- MarketBeat：回顾中的一周8/1-8/5
- 如何利用高贝塔系数股票最大化你的投资利润
- 克罗诺斯集团(Cronos Group Inc.)营收上升，是时候收购了吗？
- Beyond Meat不是没有希望，而且它很便宜
- 苹果为何可能在年底创下历史新高
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
接受Progyny Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Progyny和相关公司的最新新闻和分析师评级的每日简要摘要。
译文内容由第三方软件翻译。